Biolargo, Inc. is listed today as Biolargo Inc. : market value, financials and filings are on its company page.
Funding rounds 2 counted as startup funding. Open the number of investors for the round's details.
Funding rounds of Biolargo, Inc. Month Raised Raise Size Investors Sold Filing Jan 2012 $1 M No. 2 Under $2 million 32
Biolargo, Inc.: Raise no. 2, Jan 2012 × Investors in this round 32 investors had bought by the notice of May 30, 2012: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered; $0 M still to sell
Smallest investment taken $10,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees $64,500
Paid to its own people $300,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Charles K. Dargan · Executive Officer Dennis P Calvert · Executive Officer, Director Joseph L. Provenzano · Executive Officer, Director Kenneth R. Code · Executive Officer, Director Dennis E. Marshall · Director Gary A. Cox · Director John S. Runyan · Director Kent C. Roberts, II · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “$1,000,000 offering subject to over-allotment of 15%. Offering closed.”Signed by Dennis P. Calvert, President. Newest notice filed May 30, 2012. Read the notice at the SEC .
equity, options SEC Aug 2010 $1 M No. 1 Under $2 million 41
Biolargo, Inc.: Raise no. 1, Aug 2010 × Investors in this round 41 investors had bought by the notice of Jan 28, 2011: 41 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken $10,000
What was sold equity
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees $76,100
Paid to its own people $367,433 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Charles K Dargan, Ii · Executive Officer Dennis P Calvert · Executive Officer, Director Joseph L Provenzano · Executive Officer, Director Kenneth Reay Code · Executive Officer, Director Dennis E Marshall · Director Gary A Cox · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Wes Larsen · Mission Viejo, California Sold in CA Mark Fissore · Columbia, South Carolina Sold in CA, FL, and outside the US Bruce Kelber · Orange, California Sold in CA Jim DeFord · Mission Viejo, California Sold in CA Trevor Leeds · Newport Beach, California Sold in AZ, CA, WA Remarks in the notice On the amounts: “Offering closed”Signed by Dennis P. Calvert, President. Newest notice filed Jan 28, 2011. Read the notice at the SEC .
equity SEC
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Biolargo Inc., its revenue in fiscal 2025 came from these business segments: Odor-No-More $5.90 million (76%), BioLargo Engineering, Science & Technologies, LLC $2.54 million (33%), BioLargo Canada $90,000 (1%).
Annual report (SEC XBRL) · Dec 2025
Biolargo, Inc. had revenue of up to $1 million when it filed its newest notice of a funding round (May 2012).
SEC Form D (revenue range) · May 2012
The industry group it chose in its notices: Other.
SEC Form D · May 2012
No products or services of Biolargo, Inc. are on record.
No investor of Biolargo, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Largest shareholders today Institutions holding Biolargo Inc. shares, as of Sep 30, 2026.
As of Sep 30, 2026
Executives and directors As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by Biolargo, Inc. Name Role Named in Charles K. Dargan Executive officer May 2012 Dennis P Calvert Executive officer May 2012 Joseph L. Provenzano Executive officer May 2012 Kenneth R. Code Executive officer May 2012 Charles K Dargan, Ii Executive officer Jan 2011 Joseph L Provenzano Executive officer Jan 2011 Kenneth Reay Code Executive officer Jan 2011 Dennis E. Marshall Director May 2012 Dennis P Calvert Director May 2012 Gary A. Cox Director May 2012 John S. Runyan Director May 2012 Joseph L. Provenzano Director May 2012 Kenneth R. Code Director May 2012 Kent C. Roberts, II Director May 2012 Dennis E Marshall Director Jan 2011 Gary A Cox Director Jan 2011 Joseph L Provenzano Director Jan 2011 Kenneth Reay Code Director Jan 2011
Went public since 2012. Its SEC number is that of a company listed on a stock exchange.